Abortion Drug Restrictions Should Be Lifted, Medical Experts Say

Restrictions surrounding an abortion pill should be lifted, which would provide easier access for pregnant women, because the benefits of mifepristone greatly outweigh the risks, according to a group of medical experts.

Although mifepristone, also known as RU-486, was approved in 2000, it is subject to a Risk Evaluation and Mitigation Strategy (REMS), a set of strict regulations placed on a drug believed to have a limited safety record or that may have serious risks to patients.

But a group of 10 doctors, public health and legal experts, writing in the New England Journal of Medicine, say that decades of experience with mifepristone, both here and abroad, indicate the burdensome regulations are unnecessary and the drug should be made more readily available. They say the REMS should be lifted, given the drug’s track record of very few adverse events.

The drug is available today, but it can only be given to a patient at a clinic or hospital by a certified provider. However, since the number of abortion providers has declined, many women must travel long distances to get the drug.

In addition, the women must be given a medication guide and sign an agreement that they understand mifepristone’s risk. While other drugs, such as antibiotics, insulin and high blood-pressure medication, can cause immediate, serious reactions, they are not subject to the kind of restrictions mifepristone is. The group wants the drug treated like most other FDA-approved medications, so it is available to women with a prescription through a pharmacy.

“The reasons for the REMS are just no longer tenable,” Paul Blumenthal, MD, a professor of obstetrics and gynecology at Stanford School of Medicine who is a member of the group, told Stanford’s Scope Blog. “The drug has proven itself. It can be regulated just like any other drug… If this were Viagra, men would not stand for it.”


Jonathan Block

Jonathan Block

Jonathan Block is a freelance writer and former MedShadow content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including BioCentury, The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

Can Convalescent Plasma Treat COVID-19 Patients?

Can Convalescent Plasma Treat COVID-19 Patients?

One of the most promising treatments for COVID-19 is convalescent plasma, a component of blood. People who have been infected with the virus and are now healthy have developed COVID-19-fighting antibodies, which, the theory is, can be given to people currently sick with COVID-19 so that those antibodies can boost…

  • Advertisement